20 Austin Blvd.
Commack, NY 11725
August 8, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Scienture Holdings, Inc. Registration Statement on Form S-3 File No. 333-289198 |
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-3 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on August 8, 2025, or as soon thereafter as practicable.
We understand that the staff of the Securities and Exchange Commission will consider this request as confirmation by Scienture Holdings, Inc. that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
| Very truly yours, | ||
| SCIENTURE HOLDINGS, INC. | ||
| By: | /s/ Narasimhan Mani | |
| Name: | Narasimhan Mani | |
| Title: | Co-Chief Executive Officer and President | |
| cc: | Kate Bechen, Esq. |